Tag: LABS.TO

CannabisNewsBreaks – MediPharm Labs Corp. (TSX: LABS) Secures C$37.8M in Private Placement

MediPharm Labs (TSX: LABS), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, has closed a private placement with an institutional investor for aggregate gross proceeds of C$37,822,500. According to the update, MediPharm Labs intends to use the proceeds for general corporate purposes, including building on the launch of its cannabis 2.0 offerings with new product formats and expanding its product and active pharmaceutical ingredient exports. In addition, the proceeds will strengthen the company’s balance sheet in successful navigation through the economic recession created by the COVID-19 pandemic. Roth Capital Partners acted as sole placement agent for the offering.

To view the full press release, visit http://cnw.fm/VREED

About MediPharm Labs Corp.

Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research-driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision -dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, consumer-tests, processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian extraction facility. MediPharm Labs Australia was established in 2017. For more information, please visit www.MediPharmLabs.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CanadianCannabisWire is part of the InvestorBrandNetwork.

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) brings a pharmaceutical perspective to the cannabis industry, working to internationally recognized pharma-quality standards which result in products that are pure, trusted and precisely doseable for patients and end consumers. MediPharm Labs specializes in the creation and formulation of bulk active pharmaceutical ingredients (API’s) as well as the sale of white-labeled formulated finished products to a wide range of corporate partners in addition to its own proprietary, MediPharm Labs-branded products. MediPharm is currently working on the production of 60 different products and supplying API’s to clients in Australia, Europe, North America as well as the Asia-Pacific region.

Keith Strachan, President and Co-Founder at MediPharm Labs, will be participating in a Fireside Chat together with Tony Noto, Cannabis Editor at Benzinga.

To learn more about MediPharm Labs, visit https://www.medipharmlabs.com/

For registration information and further details on Benzinga’s Cannabis Capital Conference, visit https://www.benzinga.com/events/cannabis/detroit/

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, covers dozens of investor conferences and online events as part of its ongoing service to the investment community. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of each featured session.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its many event collaborations in 2020, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New President, Secretary; Appoints New Member to Board of Directors

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced the appointment of Pat McCutcheon to the company’s board of directors, effective immediately. McCutcheon is currently the chief executive officer of one of the leading global cannabis companies, MediPharm Labs Corp. (TSX: LABS), and has held senior roles with various large pharmaceutical companies. Champignon also announced the appointment of Matthew Fish, JD as president and secretary. In his private practice as a securities lawyer, Fish has established expansive knowledge regarding public companies, capital markets, and mergers & acquisitions. Fish will utilize his experience to assist SHRM in fast-tracking its North American new clinical entity roll-out. “We are tremendously pleased to have Pat join the Champignon Board,” Champignon CEO and director Gareth Birdsall stated in the news release. “His extensive experience in commercial development across the pharmaceutical industry combined with direct experience operating and scaling highly profitable businesses further strengthens our board with expertise that will accelerate the expansion of our clinical footprint via the establishment of net new clinical entities, as well as industry partnerships for ketamine, psilocybin and MDMA.”

To view the full press release, visit http://cnw.fm/m2mTZ

About Champignon Brands Inc.

Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://cnw.fm/SHRM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – technical420 Highlights Five Cannabis Businesses Positioned to Benefit from Global Industry Growth

Five cannabis industry players were recently highlighted in an article authored by Anthony Varrell on technical420 titled ‘The Cannabis Trade Continues To Be “The Big Long” Amid Rapid Global Growth’. The article identifies Canopy Growth (TSX: WEED) (NYSE: CGC), Canrim Growth Group, Aleafia Health (TSX: ALEF) (OTCQX: ALEAF), MediPharm Labs (TSX: LABS) (OTCQX: MEDIF), and Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) as cannabis businesses that are set to benefit from the anticipated growth within the cannabis industry. “An important trend that we have identified in the cannabis sector is related to the expected growth of the industry from a revenue standpoint. Over the next decade, the global cannabis industry is forecast to witness unprecedented growth as new markets come on-line and existing markets mature,” StoneBridge Partners Managing Director Anthony Varrell writes. “Estimates associated with the legal cannabis industry have been increasing and we are favorable on the implications this will have on the companies that are capitalizing on the global cannabis market.”

To view the full article, visit http://cnw.fm/0dNW7

About technical420

Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. It highlights companies that have the most growth potential by utilizing its proprietary analytics platform. For more information, visit www.technical420.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – technical420 Highlights Potential Acquirers, Acquisition Targets as 2020 Shapes to be a Bounce-Back Year for Cannabis M&A

A recent editorial by Anthony Varrell of technical420 reviews a slowdown in merger and acquisition (M&A) activity in the cannabis sector during the last year and its expected positive trend and bounce back in 2020 and moving forward. The article highlights three companies thought to be potential acquirers, including Canopy Growth (TSX: WEED) (NYSE: CGC), MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) and Jushi Holdings (CSE: JUSH), as well as companies technical420 believes could be potential acquisition targets, including Stem Holdings (CSE: STEM) (OTCQX: STMH), Fire & Flower Holdings Corp. (TSX: FAF) (OTC: FFLWF) and WeedMD (TSX.V: WMD) (OTCQX: WDDMF). “Several high-profile acquisitions that were announced in 2019 have been terminated or are still pending. The closing of these acquisitions will be a positive trend for the sector, and we expect to see a bounce back in the cannabis M&A market in 2020 and beyond,” Varrell writes. “Once valuations start to improve, we expect to see a significant increase in the amount of M&A activity, and this is a trend that we will continue to monitor.”

To view the full article, visit http://cnw.fm/EMjj4

About technical420

Technical420 is dedicated to educating investors about the risk and rewards of investing in the cannabis industry. It highlights companies that have the most growth potential by utilizing its proprietary analytics platform. For more information, visit www.technical420.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.